• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

September 7, 2017

Trending News Today: CHIP Reauthorization in Jeopardy Due to Healthcare Reform

Author(s):

Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

The Children’s Health Insurance Program (CHIP), which provides health coverage for low-income children, is up for renewal at the end of September 2017. Due to the resources that will need to be devoted to Hurricane Harvey clean up and keeping the government open, advocates worry that CHIP reauthorization and funding may be in jeopardy, according to Kaiser Health News. If funding for the program is reduced or lawmakers limit eligibility, it could affect more than 9 million currently-insured children. With a full legislative calendar for this month and other healthcare priorities, such as repealing the Affordable Care Act, experts are concerned that broad support for the program may falter, according to the article.

Bipartisan state insurance regulators are urging Congress to seek an accelerated plan to stabilize the health insurance marketplace, according to the Los Angeles Times. The officials recommend that lawmakers keep subsidies as part of their combined effort to move forward and fill gaps left by the ACA. Since many insurers are considering hiking premiums without action by the end of September, the regulators are calling on lawmakers to pass a bill quickly, as prolonged uncertainty can have negative effects on the market, the Times reported.

Participating in aerobic fitness may change how cells work in a way that could reduce the risk of breast cancer, according to The New York Times. A new animal study found that physically fit rats were less likely to develop cancer after exposure to carcinogens, suggesting that fitness could stave off the disease. These results remained true even if rats did not participate in exercise but were genetically fit. The authors hypothesize that genetic fitness may reduce the risk of cancer, in addition to participating in cardiovascular exercises, according to the article.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Advertisement
Acalabrutinib capsules | Image Credit: © luchschenF - stock.adobe.com
August 15th 2025

Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Pharmacist drawing vaccine from vial | Image Credit: © Alernon77 - stock.adobe.com
August 15th 2025

KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Lung adenocarcinoma -- Image credit: MdBabul | stock.adobe.com
August 15th 2025

High Perilipin 2 Expression Associated With Disease Progression, Shorter Survival in Lung Adenocarcinoma

Gillian McGovern, Associate Editor
From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL
August 15th 2025

From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL

Ami Ali, PharmD, BCOP Melissa Martinez, PharmD Martina Nasralla, PharmD Candidate Zyanya Rizzo, PharmD Candidate Lamya Al-Saleh, PharmD, RPh
Related Content
Advertisement
Acalabrutinib capsules | Image Credit: © luchschenF - stock.adobe.com
August 15th 2025

Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Pharmacist drawing vaccine from vial | Image Credit: © Alernon77 - stock.adobe.com
August 15th 2025

KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Lung adenocarcinoma -- Image credit: MdBabul | stock.adobe.com
August 15th 2025

High Perilipin 2 Expression Associated With Disease Progression, Shorter Survival in Lung Adenocarcinoma

Gillian McGovern, Associate Editor
From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL
August 15th 2025

From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL

Ami Ali, PharmD, BCOP Melissa Martinez, PharmD Martina Nasralla, PharmD Candidate Zyanya Rizzo, PharmD Candidate Lamya Al-Saleh, PharmD, RPh
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.